 "Urgent Response to Mpox Crisis: UNICEF’s Race for Life-Saving Vaccines")
UNICEF has launched an emergency tender to secure monkeypox (mpox) vaccines as the outbreak escalates in the Democratic Republic of the Congo, which has reported over 18,000 suspected cases and 629 deaths, primarily among children. This effort, in collaboration with organizations like the Africa CDC and WHO, aims to ensure vaccine availability in the hardest-hit regions. The tender will create agreements with vaccine manufacturers for rapid distribution once financing and regulatory requirements are met. Alongside vaccines, UNICEF is also providing essential medical supplies and support for prevention and community engagement efforts to combat the ongoing crisis. There is a pressing need for equitable vaccine allocation to protect vulnerable populations.
UNICEF Steps Up Efforts to Combat Mpox Outbreak in Congo
As the Democratic Republic of the Congo faces a severe mpox outbreak, UNICEF has announced an emergency tender for the procurement of vaccines to help control the crisis. This year alone, the country has reported over 18,000 suspected cases, resulting in 629 deaths, predominantly affecting children.
The urgency of this situation has prompted UNICEF to collaborate with key organizations, including the Africa Centres for Disease Control and Prevention, Gavi, and the World Health Organisation. Their goal is not only to secure vaccines for the most affected areas but also to facilitate the donation of vaccines from high-income countries to reduce the virus’s spread.
Under this emergency initiative, UNICEF will form conditional supply agreements with vaccine manufacturers to ensure that the vaccines can be delivered promptly once the financing and demand are confirmed. The World Health Organisation is currently reviewing the necessary information from manufacturers and expects to complete this process by mid-September.
Leila Pakkala, Director of UNICEF’s Supply Division, emphasized the importance of addressing the current vaccine shortage and highlighted the need for a fair distribution system to ensure that those most in need have access to the vaccines. The aim is to establish agreements for up to 12 million vaccine doses by 2025, contingent on demand and production capacity.
In addition to vaccines, the initiative includes a comprehensive plan to enhance infection prevention and control measures. UNICEF is also providing essential medical supplies, such as personal protective equipment, diagnostic tests, and hygiene kits, to support countries on the frontline of this health crisis.
Tags: UNICEF, mpox, Democratic Republic of the Congo, vaccine procurement, public health emergency, Africa CDC, WHO, health crisis.
What is mpox, and why are vaccines needed?
Mpox, also known as monkeypox, is a viral disease that can spread easily in some areas. Vaccines can help prevent the spread and protect people, especially in countries most affected by the disease.
Who is UNICEF working with for these vaccines?
UNICEF is partnering with governments, health organizations, and international agencies to secure and distribute mpox vaccines to the countries that need them the most.
How will UNICEF ensure the vaccines reach the affected countries?
UNICEF has a strong supply chain network and experience in vaccine delivery. They will coordinate with local health authorities to make sure the vaccines are distributed quickly and efficiently.
What are the symptoms of mpox?
Symptoms of mpox can include fever, rash, and swollen lymph nodes. It’s important for anyone who experiences these symptoms, especially in high-risk areas, to seek medical help.
Can everyone get vaccinated against mpox?
Currently, the vaccines are prioritized for people at higher risk, including healthcare workers and those who have been in close contact with infected individuals. Public health guidelines will determine broader access as needed.
